Human Xtensions: The AI Deal, the NIS 19 Million Raise, and What Actually Remains for Public Shareholders
The 15.84% figure sounds like what remains for the public in the AI transaction, but the filings define it as the whole company-shareholder bucket after the pre-closing raise. Once the NIS 100 million valuation floor is lined up against the NIS 19 million cash condition, the legacy shell is being credited with only about NIS 1 million before any bridge financing.
What This Follow-Up Is Isolating
The main article already established the broader frame: Human Xtensions is now a listed shell with limited cash, a going-concern warning, and very little time to inject new activity. This follow-up does not revisit that wider story. It isolates only the February 2026 AI-related memorandum and asks one narrower question: if this deal closes, how much of the new company actually remains with today’s public shareholders, and how much of the future upside has already been allocated to fresh money and the deal adviser.
The answer starts with four hard facts. First: 15.84% is not the stake of the current public by itself, but the stake of "the company’s shareholders, including after the pre-closing capital raise." Second: the NIS 100 million valuation floor for the target implies a minimum post-deal equity value of about NIS 126.3 million. Third: under that math, the entire company-shareholder bucket is worth only about NIS 20.0 million, while the deal requires at least NIS 19 million to be sitting in cash at closing. Fourth: as of December 31, 2025 the company had only NIS 991 thousand of cash, and the board wrote that without a capital raise and without completion of the old sale cash would last only until May 2026.
| Disclosed term | What the filing says | Why it matters |
|---|---|---|
| Target shareholders | 79.18% on a fully diluted basis | Economic control shifts overwhelmingly to the acquired business |
| Company shareholders | 15.84%, including after the pre-closing raise | This is not necessarily the legacy public’s clean residual stake |
| Investment banker | 4.99% | Another dilution layer before the new activity is proven |
| Target valuation floor | NIS 100 million | Sets the minimum implied valuation for the whole transaction |
| Minimum cash at closing | NIS 19 million | Makes this first and foremost a financing test |
| Trading condition | Listing approval for the new shares and principal approval to return to the main list | This is also a relisting transaction, not only an acquisition |
This chart matters because of what it does not show. It tells you who is supposed to own the company after completion, but it does not separate legacy shareholders from the investors who will fund the pre-closing raise. That distinction is where the whole dilution analysis starts.
15.84% Is Not What Remains For Today’s Public
This is the key starting point. The filing does not say that current shareholders remain with 15.84%. It says that the company’s shareholders, including after the pre-closing capital raise, will hold 15.84%. In other words, that slice contains both the shareholders of today and whoever comes in with fresh money before closing.
This is not a consideration split. It is a post-financing ownership split. That is why 15.84% cannot be treated as a number automatically belonging to the current public. Until the company discloses the issue price, the amount of stock to be sold, and who will participate in the raise, there is no way to know the exact residual stake of existing holders. What can be said with confidence is that their final share must be below 15.84% if most of the raise is taken by new investors, and can move closer to that number only if current holders themselves inject new cash.
That changes the right way to read the deal. A superficial reading suggests that the public still keeps a double-digit stake. The economic reading is different: the public sits inside a bucket that is being recapitalised immediately before closing. So the real question is not simply "what percentage remains," but how much of the 15.84% is effectively repurchased with new money, and how much truly belongs to the old shell.
| What is already known | What is still undisclosed |
|---|---|
| The company must reach closing with NIS 19 million of cash | The issue price of the pre-closing raise |
| The company-shareholder bucket after closing is 15.84% | How much of that bucket will be bought by new money |
| The investment banker receives 4.99% | Who exactly will participate in the raise |
| The target has a NIS 100 million valuation floor | What valuation the target gets if it clears the floor |
This table shows why the ownership percentages alone are not enough. The documents disclose the ownership structure, but not yet the economic entry terms of the new money. Without those terms, the real price of staying inside the deal is still incomplete.
The Valuation Floor Does Most Of The Math
At first glance the NIS 100 million floor looks like protection for the sellers. In practice it also reveals the minimum value the transaction assigns to the public-side vehicle. If 79.18% is worth at least NIS 100 million, then the minimum post-deal equity value is about NIS 126.3 million. That means the 15.84% company-shareholder bucket is worth about NIS 20.0 million, while the 4.99% investment-banker allocation is worth about NIS 6.3 million.
Now comes the key step. That roughly NIS 20.0 million company-shareholder bucket also has to absorb the pre-closing raise, which must leave at least NIS 19 million of cash on the balance sheet at closing. In other words, at the minimum disclosed valuation almost the entire public-side bucket is explained by the cash that has to be brought into the company just to make the deal closable. What is left for the legacy shell itself is only about NIS 1 million, before any bridge financing that might be needed on the way to closing.
That is not proof that the target is worth only NIS 100 million. If the external valuation comes in higher, the math changes. But as long as the filings disclose only a floor and not a final price, the floor already tells the core story: in the minimum case that still allows the transaction to move ahead, the legacy public side is not really selling a meaningful operating business. It is mainly handing over control of a listing vehicle in exchange for new cash and a new operating asset.
This chart is the core of the follow-up. Even without knowing the final price, it shows that the disclosed floor leaves only a very small standalone value for the shell itself. If bridge financing is used before completion, and the memorandum explicitly leaves room for that, even that NIS 1 million residual is not necessarily a hard lower bound.
The Funding Test: NIS 19 Million Is The Floor, Not The Finish Line
This is the right place to switch to an all-in cash flexibility frame. The question is not how much cash a business that no longer exists can generate. The question is how much cash has to arrive in the company so that the deal can satisfy its closing conditions.
At year-end 2025 the company had NIS 991 thousand of cash and cash equivalents, NIS 1.49 million of working capital, and NIS 1.49 million of equity, with no financial debt. That sounds clean. It does not sound funded. The NIS 19 million cash condition is roughly 19 times the year-end cash balance, and even on that static year-end base the immediate gap is about NIS 18.0 million.
That gap is not necessarily the final gap either. The memorandum explicitly says that the pre-closing raise may also be used to repay bridge financing if the company takes such financing before completion. So NIS 19 million is a minimum cash balance at closing, not necessarily the gross amount that has to be raised. If bridge money is needed on the way, the economic cost to current shareholders could be even heavier, whether through deeper dilution or a more expensive capital structure.
That is exactly why the board wrote that, without a public capital raise and without completion of the old sale, cash is expected to last only until May 2026, and why the auditor highlighted a going-concern issue because current funding sources are not sufficient for 12 months from the approval date of the financial statements. The new deal is not landing on a full treasury. It is landing on a shell that needs a large and fast financing event just to remain in the process.
This Is Also A Relisting Transaction, Not Only An Acquisition
There is one more common reading mistake here: to treat this as ordinary M&A. That is not precise. Human Xtensions was already classified in 2025 as a shell company, and its shares were moved to the preservation list. The annual report states that a shell company seeking a return to the main list must satisfy the conditions applicable to a new company, and the memorandum turns that into an explicit closing condition: approval to list the newly issued shares and principal approval to return the company’s shares to the main list.
So there are really four tests running in parallel: a detailed binding agreement, a valuation that does not fall below the floor, a financing event that leaves NIS 19 million in cash at closing, and a regulatory path that gets the stock back to normal trading status. It takes only one of those four to fail for the transaction to remain an idea rather than a real reset.
| What must happen | Why it matters |
|---|---|
| A detailed agreement must be signed within the 60-day window | Without a binding agreement there is no deal, only a cancellable memorandum |
| The target must be valued at at least NIS 100 million, or the parties must agree on adjustments | That is the explicit valuation floor the documents set |
| The financing must leave NIS 19 million of cash even if bridge financing was used | Otherwise the core funding condition is not met |
| Shareholder, regulatory, and exchange approvals must be obtained, including the route back to the main list | Without relisting clearance, even a signed transaction does not complete the reset |
Bottom Line
On the surface, the AI deal looks like a path to inject a new business and close the shell chapter. Under a colder reading, it does four things at once: it brings in a new operating activity, resets economic control, requires a very large capital raise relative to the current cash balance, and subjects the whole path to a relisting process. That is not necessarily a bad move. It is an expensive one.
Current thesis: 15.84% is not what remains for today’s shareholders. It is the entire public-side bucket after the pre-closing raise. At the disclosed valuation floor, almost all of that bucket is explained by the NIS 19 million of cash that has to enter the company, which means the legacy shell itself is being credited with only about NIS 1 million before bridge financing.
What has to happen next for the read to improve is fairly clear: sign a detailed agreement, show that the valuation clears the floor, disclose the financing terms so the real residual stake of current holders can be measured, and establish a credible path back to the main list. Without those four pieces, this is not really a growth transaction. It is a financing and dilution transaction wearing the form of an acquisition.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.